TTY Biopharm Co Ltd (4105) — Cash Flow Quality Index
TTY Biopharm Co Ltd (4105) has a Cash Flow Quality Index of 2.57x as of December 2025. Operating cash flow of NT$778.89 Million exceeds net income of NT$303.21 Million, indicating high earnings quality where cash backs reported profits. Explore TTY Biopharm Co Ltd cash conversion from operations to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
TTY Biopharm Co Ltd Cash Flow Quality Index (2017–2025)
Historical Cash Flow Quality Index for TTY Biopharm Co Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check TTY Biopharm Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for TTY Biopharm Co Ltd (2017–2025)
Year-by-year earnings quality comparison for TTY Biopharm Co Ltd. For live market cap and the full company financial profile, see TTY Biopharm Co Ltd market cap and net worth.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.13x | NT$1.76 Billion | NT$1.56 Billion | ▲ +21.4% |
| 2024 | 0.93x | NT$1.35 Billion | NT$1.45 Billion | ▲ +21.7% |
| 2023 | 0.76x | NT$1.09 Billion | NT$1.42 Billion | ▼ -12.9% |
| 2022 | 0.88x | NT$1.24 Billion | NT$1.41 Billion | ▼ -24.1% |
| 2021 | 1.16x | NT$1.26 Billion | NT$1.09 Billion | ▲ +163.7% |
| 2020 | 0.44x | NT$526.35 Million | NT$1.20 Billion | ▼ -67.4% |
| 2019 | 1.34x | NT$1.21 Billion | NT$900.08 Million | ▲ +82.9% |
| 2018 | 0.73x | NT$1.07 Billion | NT$1.46 Billion | ▼ -0.8% |
| 2017 | 0.74x | NT$996.52 Million | NT$1.34 Billion | — |